Drugs
?
-
2012 Drug Safety Communications
-
- Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves
12/19/2012 - Serious skin reactions after combination treatment with the Hepatitis C drug Incivek (telaprevir), peginterferon alfa, and ribavirin
12/19/2012 - Warning against use of Xyrem (sodium oxybate) with alcohol or drugs causing respiratory depression
12/17/2012 - Safety review update of Chantix (varenicline) and risk of cardiovascular adverse events
12/12/2012 - Important change to heparin container labels to clearly state the total drug strength
12/6/2012 - Updated information on 32 mg intravenous ondansetron (Zofran) dose and pre-mixed ondansetron products
12/4/2012 - Update on the risk for serious bleeding events with the anticoagulant Pradaxa
11/2/2012 - Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays
10/25/2012 - Ongoing safety review of Parkinson’s drug Mirapex (pramipexole) and possible risk of heart failure
9/19/2012 - Rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers
9/13/2012 - FDA recommends against use of Revatio in children with pulmonary hypertension
8/30/2012 - Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death
8/15/2012 - Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)
7/23/2012 - New information regarding QT prolongation with ondansetron (Zofran)
6/29/2012 - Cefepime and risk of seizure in patients not receiving dosage adjustments for kidney impairment
6/26/2012 - Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)
5/14/2012 - Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies
5/7/2012 - Updated information on drug interactions between Victrelis (boceprevir) and certain boosted HIV protease inhibitor drugs
4/26/2012 - New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)
4/20/2012 - Updated information about the risk of blood clots in women taking birth control pills containing drospirenone
4/10/2012 - Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses
3/28/2012 - Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury
3/1/2012 - Important safety label changes to cholesterol-lowering statin drugs
3/12/2012 - CardioGen-82 - Planned return of CardioGen-82 to market with new Boxed Warning
2/15/2012 - Victrelis - Important drug interactions between Victrelis (boceprevir) and ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitor drugs
2/8/2012 - Proton Pump Inhibitors - Clostridum difficile -associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)
2/8/2012 - Tysabri - New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
1/20/2012 - Adcetris - New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)
1/13/2012 - CardioGen-82 - Update: Preliminary findings from ongoing investigations of CardioGen-82
1/12/2012
-
-
-
